Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

New Drug Submission for Ditropan accepted for review in Canada

March 10, 1999

Microbially produced 5alpha-reductase inhibitor discovered at Snow Brand

March 9, 1999

Licensing opportunity from VUFB: alpha2-adrenoceptor antagonist for BPH and heart failure

Feb. 16, 1999

PKC inhibitors designed at Otsuka

Feb. 9, 1999

Alza launches Ditropan XL in the U.S.

Feb. 3, 1999

Chugai patents 2,3-dihydrobenzofurans with cytoprotective effects

Jan. 27, 1999

Oral L-arginine compared to placebo for efficacy in interstitial cystitis

Jan. 25, 1999

Therapeutic advantages of paricalcitol further defined

Jan. 25, 1999

Rochester Medical files PMA for FemSoft

Jan. 22, 1999

Improved treatments for BPH in development at Pfizer

Jan. 22, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...